Cargando…
Identification of Targets to Redirect CAR T Cells in Glioblastoma and Colorectal Cancer: An Arduous Venture
The chimeric antigen receptor (CAR) is an artificial molecule engineered to induce cytolytic T cell reactions in tumors. Generally, this molecule combines an extracellular single-chain variable fragment (scFv) able to recognize tumor-associated epitopes together with the intracellular signaling doma...
Autores principales: | Ponterio, Eleonora, De Maria, Ruggero, Haas, Tobias Longin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555836/ https://www.ncbi.nlm.nih.gov/pubmed/33101285 http://dx.doi.org/10.3389/fimmu.2020.565631 |
Ejemplares similares
-
CAR T Cells Redirected to CD44v6 Control Tumor Growth in Lung and Ovary Adenocarcinoma Bearing Mice
por: Porcellini, Simona, et al.
Publicado: (2020) -
Bladder hemangioma: An arduous diagnosis of hematuria
por: Xiao, Lekui, et al.
Publicado: (2021) -
Immunotherapy of B cell lymphoma with CD22-redirected CAR NK-92 cells
por: Tian, Xiaopeng, et al.
Publicado: (2023) -
The Story of Levodopa: A Long and Arduous Journey
por: Bhattacharyya, Kalyan B.
Publicado: (2022) -
Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)